Informations générales (source: ClinicalTrials.gov)

NCT04129021 En recrutement IDF
High Resolution and High Speed Multimodal Ophthalmic Imaging (IMA-MODE)
Interventional
  • Dystrophies héréditaires de la cornée
  • Inflammation
  • Kératocône
  • Dégénérescence maculaire
  • Oedème maculaire
  • Dégénérescence de la rétine
  • Décollement de la rétine
  • Rétinite
  • Rétinite pigmentaire
N/A
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (Voir sur ClinicalTrials)
juillet 2019
juillet 2027
16 octobre 2024
Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea. The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease. The purpose of this project is to observe structures that are not detectable with routinely used systems.
 Voir le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
CHNO DES QUINZE-VINGTS PARIS Michel PAQUES, PU-PH En recrutement IDF Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- People over 18

- Patient with a pathology affecting the eye or healthy volunteer

- Participant who signed the consent

- Beneficiaries of the health insurance


- Patients with a history of photosensitivity.

- Patients who have just received a photodynamic therapy treatment (

- Patients taking drugs with photosensitivity as a side effect.

- Persons with pacemakers or other implanted electronic medical device

- Patients with viral conjunctivitis or any other infectious disease.

- Patients with skin lesions on the neck or forehead

- Patients at high risk of damage from optical radiation, such as aphakic patients, or
patients with decreased sensitivity to light due to fundus disease.

- Pregnant or lactating women

- Participant unable to be followed throughout the study

- Vulnerable people

- Subjects with predisposition to closure of the iridocorneal angle